Cargando…
Modulating T Cell Responses by Targeting CD3
SIMPLE SUMMARY: CD3 complex provides the first signal sensed by the TCR of the lymphocyte to trigger its activation. Thus, it becomes a very attractive receptor to determine the fate of the immune response in different contexts from tolerance induction to immune activation. We discuss CD3-TCR comple...
Autores principales: | Menon, Ashwathi Puravankara, Moreno, Beatriz, Meraviglia-Crivelli, Daniel, Nonatelli, Francesca, Villanueva, Helena, Barainka, Martin, Zheleva, Angelina, van Santen, Hisse M., Pastor, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953819/ https://www.ncbi.nlm.nih.gov/pubmed/36831533 http://dx.doi.org/10.3390/cancers15041189 |
Ejemplares similares
-
A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression
por: Meraviglia-Crivelli, Daniel, et al.
Publicado: (2022) -
Therapeutic Strategies to Enhance Tumor Antigenicity: Making the Tumor Detectable by the Immune System
por: Meraviglia-Crivelli, Daniel, et al.
Publicado: (2022) -
IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction
por: Meraviglia-Crivelli, Daniel, et al.
Publicado: (2022) -
Aptamers Against Live Targets: Is In Vivo SELEX Finally Coming to the Edge?
por: Sola, Mayte, et al.
Publicado: (2020) -
ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity
por: Soldevilla, Mario Martínez, et al.
Publicado: (2019)